CLAYTON M RAMSUE
Allopathic & Osteopathic Physicians|Family Medicine ATLANTA, GA NPI 1659549103
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine GA Novo Nordisk AS All categories
General Payments — all program years on this page
$406.59
- Category: General Payments
- Program years: PY2018–2022
- Record count: 20
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $150.57 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $150.57 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $83.26 | 5 |
| Emmaus Medical, Inc. | $25.42 | 1 |
| Lilly USA, LLC | $25.25 | 1 |
| GlaxoSmithKline, LLC. | $16.64 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 898636565 | Novo Nordisk Inc | $12.56 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898915215 | Novo Nordisk Inc | $14.27 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898962647 | Novo Nordisk Inc | $20.16 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899060567 | Novo Nordisk Inc | $13.22 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899060575 | Novo Nordisk Inc | $23.05 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 917956455 | Lilly USA, LLC | $25.25 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 945042143 | GlaxoSmithKline, LLC. | $16.64 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 960497663 | Emmaus Medical, Inc. | $25.42 | 01/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.